ReCode Therapeutics

Biopharma, Biotechnology, Genetics, Pharmaceutical
Founded in 1/1/15
Dallas, Texas, United States
http://www.recodetx.com
For Profit

About ReCode Therapeutics

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics. Its selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a genetic medicines technology that enables precise delivery to target organs and cells beyond the liver.

Company Metrics

  • Employees: 51-100
  • Monthly Visits: 2945
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: 422000022 USD
  • Last Funding: 10000000 USD (Venture - Series Unknown)
  • Funding Status:

Technology Stack

ReCode Therapeutics actively uses None products in their tech stack.

Market Presence

Industries: Biopharma, Biotechnology, Genetics, Pharmaceutical

Headquarters: Dallas, Texas, United States

Leadership

  • Jessica Kelly - Senior Management Associate, supporting the CEO LinkedIn

Employees

  • Shehnaaz Suliman - Chief Executive Officer and Board Member (LinkedIn)